HanchorBio Inc. 漢康生技股份有限公司
@hanchorbio.com
重塑免疫治療 漢衛眾人健康 Reimagining Immunotherapy for Patients Worldwide 引航腫瘤免疫的新領域 Our Possibility 我們的可能性 研發專案 8 + 專利申請 150 + 進入臨床IND階段 最快 2.3 年 2024年的研發投資金額 7.89 億元
HanchorBio Inc. 漢康生技股份有限公司's Company Logos
HanchorBio Inc. 漢康生技股份有限公司's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#265E9D
St Tropaz
38, 94, 157
212, 61, 38
76, 40, 0, 38
#62B6FF
Malibu
98, 182, 255
208, 100, 69
62, 29, 0, 0
#004A59
Sherpa Blue
0, 74, 89
190, 100, 17
100, 17, 0, 65
About HanchorBio Inc. 漢康生技股份有限公司
HanchorBio is a leading biotech brand that specializes in the development of biological medicines using their revolutionary IgG Fc-Based Designer Biologics (FBDB™) platform. Their mission is to transcend the field of Immuno-Oncology therapeutics by creating cutting-edge designer biologics with innovative modalities for cancer patients. Founded by Dr.
Scott Liu, who has over 30 years of experience in biotech R&D and corporate development, HanchorBio is an independent spin-off from Henlius-TW (Henlix Biotech). Under Dr. Liu's leadership, Henlius became a top biopharma company in China, with a valuation of approximately US$3 billion and three commercial mAb products launched in China and the EU.
At HanchorBio, the culture of emphasis on innovation, quality, and speed is nurtured. Their core values include innovation, integrity, execution, excellence, accountability, teamwork, and leadership. With their commitment to transforming innovative drug development in biologics, HanchorBio aims to be a pioneering biotech company that revolutionizes the field of biomedicine with novel modalities
Company type
Privately Held
Year founded
2020
Company size
11-50 employees
